Skip to main content
MedPathMedPath Home
Clinical Trials/CTRI/2021/04/032976
CTRI/2021/04/032976
Completed
未知

Accelerating Access And Uptake Of HIV Self-Testing (HIVST) In India-An Implementation Study - HIVST DEMO_STUDY

Population Services International0 sites0 target enrollmentTBD
Share to TwitterShare to FacebookShare to LinkedInShare to Reddit

Overview

Phase
未知
Intervention
Not specified
Conditions
Not specified
Sponsor
Population Services International
Status
Completed
Last Updated
2 years ago
OverviewInvestigatorsEligibility CriteriaOutcomesSimilar Trials

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
TBD
End Date
June 30, 2023
Last Updated
2 years ago
Study Type
Interventional

Investigators

Sponsor
Population Services International

Eligibility Criteria

Inclusion Criteria

  • •At risk population /regular sex/Injecting partners of at\-risk population contacted through different service delivery models who are willing for HIVST, persons completed 18 years of age and Consenting to share their HIVST results

Exclusion Criteria

  • •Individuals who know their status as HIV positive will not be eligible for HIVST.

Outcomes

Primary Outcomes

Not specified

Similar Trials

Active, not recruiting
Not Applicable
An Expanded Access trial in Japan to provide spesolimab to people with a flare-up in Generalized Pustular Psoriasis who have no other treatment optionsGeneralized Pustular Psoriasis (GPP)
JPRN-jRCT2071210127Ohno Masashi3
Not yet recruiting
Phase 2
An Open Label, Multi Centre, Phase II Study to Evaluate the Safety and Efficacy of Coramsine Injection in Patients with MelanomaAdvanced MelanomaCancer - Malignant melanoma
ACTRN12606000330549Solbec Pharmaceuticals Ltd56
Not yet recruiting
Phase 2
An Open Label, Multi Centre, Phase II Study to Evaluate the Safety and Efficacy of Coramsine Injection in Patients with Renal Cell CarcinomaAdvanced Renal Cell CarcinomaCancer - Renal Cell Carcinoma
ACTRN12606000099527Solbec Pharmaceuticals Ltd56
Completed
Phase 1
A clinical trial to study the safety and efficacy of a new compound P276-00 in the treatment of multiple myelomaHealth Condition 1: null- Multiple Myeloma
CTRI/2008/091/000004Piramal Life Science26
Active, not recruiting
Phase 1
Multicentre, open phase II trial to evaluate safety and efficacy of a perioperative chemotherapy with docetaxel, cisplatin and capecitabin in patients suffering from adenocarcinoma of the stomach, gastroesophageal junction or distal esophagus.
EUCTR2008-001849-26-DECharité - Universitätsmedizin Berlin50